PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
35464198-10	2022	Furthermore, compared to treatment with LPS, treatment with GMSC-Exo attenuated the expression of NF-kappaB signaling and Wnt5a in LPS-induced PDLSCs.	gmsc	60-64	nuclear factor kappa B subunit 1	Homo sapiens	98-107	
34953015-7	2022	The results show that GMSC-Exo has the same or stronger effects compared with GMSC in inhibiting IL-17A and promoting IL-10, reducing incidences and bone erosion of arthritis, via inhibiting IL-17RA-Act1-TRAF6-NF-kappaB signal pathway.	gmsc	22-26	nuclear factor kappa B subunit 1	Homo sapiens	210-219	
34953015-7	2022	The results show that GMSC-Exo has the same or stronger effects compared with GMSC in inhibiting IL-17A and promoting IL-10, reducing incidences and bone erosion of arthritis, via inhibiting IL-17RA-Act1-TRAF6-NF-kappaB signal pathway.	gmsc	78-82	nuclear factor kappa B subunit 1	Homo sapiens	210-219	
35464198-11	2022	In conclusion, we confirmed that GMSC-Exo could suppress the inflammatory response of PDLSCs by regulating the expression of NF-kappaB signaling and Wnt5a, which paves the way for the establishment of a therapeutic approach for periodontitis.	gmsc	33-37	nuclear factor kappa B subunit 1	Homo sapiens	125-134	
31076346-6	2019	GMSC treatment also resulted in a dramatically decreased level of NF-kappaB p65/p50 in osteoclasts in vitro.	gmsc	0-4	nuclear factor kappa B subunit 1	Homo sapiens	80-83